HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S1P(1)-selective agonist, SEW2871, ameliorates ischemic acute renal failure.

Abstract
The pathogenesis of renal ischemia/reperfusion (I/R) injury involves activating several signal transduction cascade systems in endothelial cells. Sphingosine 1-phospate (S1P) maintains endothelial cell integrity and inhibits lymphocyte egress via the specific S1P(1) receptor, and may play a role in reducing ischemic renal injury. We examined the protective effects of a newly identified S1P(1)-selective agonist, SEW2871, on mouse renal I/R injury. Kidneys were harvested 1-4 days after I/R injury for histopathology, immunofluorescence studies, and quantitative real-time reverse transcriptase-polymerase chain reaction analyses to assess the change in gene expression profiles of inflammation-associated cytokines and adhesion molecules. SEW2871 improved renal function with a 40% reduction in plasma creatinine levels (P<0.01) and a significant reduction in tubular necrosis scores (I/R only: 4.3+/-0.2 vs I/R+SEW2871: 2.5+/-0.4, P<0.05) 24 h after ischemia. These changes were accompanied by 69% reduction in circulating lymphocytes, and 77 and 66% reduction in infiltrating neutrophils and macrophages in renal outer medulla, respectively (all P<0.01). The mRNA abundance of tumor necrotic factor-alpha (TNF-alpha), P-selectin, E-selectin, and intercellular adhesion molecule-1 (ICAM-1) was markedly increased by I/R injury (3.5-, 4.1-, 3.5-, and 4.8-folds, respectively, all P<0.05 vs sham). SEW2871 treatment partially reversed the upregulation of TNF-alpha, P-selectin, and ICAM-1 (47, 59, 54%, respectively, vs I/R control: 100%, all P<0.05). The reduction in protein expression of TNF-alpha, P-selectin, and ICAM-1 was further confirmed with immunofluorescence studies. These results suggest that SEW2871 ameliorates renal I/R injury by inhibiting lymphocyte egress and reducing pro-inflammatory molecules. This new class of renoprotective agent shows promise as a novel approach in preventing/treating ischemic acute renal failure.
AuthorsY-Hh Lien, K-C Yong, C Cho, S Igarashi, L-W Lai
JournalKidney international (Kidney Int) Vol. 69 Issue 9 Pg. 1601-8 (May 2006) ISSN: 0085-2538 [Print] United States
PMID16572108 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cell Adhesion Molecules
  • Oxadiazoles
  • RNA, Messenger
  • Receptors, Lysosphingolipid
  • SEW2871
  • Thiophenes
  • Tumor Necrosis Factor-alpha
Topics
  • Acute Kidney Injury (drug therapy, metabolism, pathology)
  • Animals
  • Cell Adhesion Molecules (genetics, metabolism)
  • Down-Regulation
  • Ischemia (drug therapy, metabolism, pathology)
  • Kidney (blood supply, metabolism, pathology)
  • Leukocyte Count
  • Male
  • Mice
  • Oxadiazoles (therapeutic use)
  • RNA, Messenger (metabolism)
  • Receptors, Lysosphingolipid (agonists)
  • Reperfusion Injury (metabolism, pathology, prevention & control)
  • Thiophenes (therapeutic use)
  • Tumor Necrosis Factor-alpha (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: